Clinical investigation5-S-Cysteinyldopa (cas 19641-92-0) as Diagnostic Tumor Marker for Uveal Malignant Melanoma

Add time:09/05/2019    Source:sciencedirect.com

Purpose: To evaluate the clinical significance of 5-S-cysteinyldopa (5-S-CD), a major intermediate in melanin synthesis, as a potential diagnostic tumor marker for uveal malignant melanoma.Methods: The levels of 5-S-CD in the serum were measured by high-performance liquid chromatography in 16 patients with primary uveal melanoma. The levels of 5-S-CD were also measured in both aqueous and vitreous humor in 10 patients with uveal melanoma. The serum of healthy volunteers and patients with skin diseases other than melanoma, and the intraocular fluids of patients with cataract and vitreoretinal diseases were used as controls.Results: Serum concentrations of 5-S-CD in patients with uveal melanoma in the absence of extraocular metastases were close to those of controls; however, serum concentrations of 5-S-CD were significantly elevated in patients with extraocular metastases of melanoma. Concentrations of 5-S-CD in the intraocular fluids, especially vitreous humor, were higher in patients with uveal melanoma than in controls.Conclusions: 5-S-CD in intraocular fluids may serve as a useful biochemical marker for the diagnosis of uveal melanoma. Serum 5-S-CD may contribute to the assessment of the presence and progression of extraocular metastases in patients with uveal melanoma.

We also recommend Trading Suppliers and Manufacturers of Cysteinyldopa (cas 19641-92-0). Pls Click Website Link as below: cas 19641-92-0 suppliers

Prev:Characterisation of 1,4-benzothiazine intermediates in the oxidative conversion of 5-S-Cysteinyldopa (cas 19641-92-0) to pheomelanins
Next:A pulse radiolysis investigation of the oxidation of the melanin precursors 3,4-dihydroxyphenylalanine (dopa) and the Cysteinyldopa (cas 19641-92-0)s)